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INTRODUCTION:  Squamous  cell  carcinoma  SCC  of the  rectum  is  a  distinct  entity.  We  report  a  very  rare
case  of squamous  cell  carcinoma  of  the  middle  rectum.
PRESENTATION OF CASE:  The  patient  was  a 62-year-old  woman  who  presented  with  a history  of rectal
bleeding  and  discomfort.  Colonoscopy  revealed  a polypoid  tumour  of the  middle  rectum.  Biopsies of
this  mass  revealed  a poorly  differentiated  SCC  of the  rectum.  CT  scan  of  the  chest,  abdomen  and  pelvis
was  negative  for  distal  metastases.  The  patient  received  combined  chemo-radiation  followed  by surgical
excision.  The  postoperative  period  was  uncomplicated.
DISCUSSION: The  pathogenesis  of  rectal SCC  remains  unclear  and  diagnosis  is often  delayed.  Diagnostichemoradiation
urgery
criteria  have  been  proposed.  MRI of  the rectum  and  trans-rectal  endoscopic  ultrasound  R-EUS provide
essential  information  to plan  a therapeutic  approach.  The  squamous  cell  carcinoma  antigen  level  is  not
suitable  for  initial  diagnosis  of rectal SCC.  Most  authors  conclude  that the  surgery  is the gold  standard
treatment.  Tumour  stage  is the most  important  prognostic  predictor  of  SCC.
CONCLUSION: Squamous  cell  carcinoma  of the  rectum  is a  distinct  entity.  Before  the  ﬁnal  choice  of
treatment  is made,  digestive  surgeons  should  bear  in  mind  this  rare tumour.
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-SA lic© 2013 The Authors. Pu
. Introduction
Colorectal cancer is the third most common cause of cancer-
elated death in the world. Squamous cell cancer SCC is an unusual
alignancy in rectum. Its incidence ranges from 0.1 to 0.25 per
000 colorectal neoplasms. Its aetiology is not exactly known. Little
nformation is available in the literature about the risk factors and
atural history, prognosis and treatment of this cancer. We  report
 case of SCC of the middle rectum which was treated success-
ully with chemoradiation and surgical resection. The incidence,
iagnostic criteria and management of this very rare tumour are
iscussed.
. Presentation of case
A 62-year-old woman presented with a history of rectal bleed-
Open access under CC BY-NCng and discomfort. The patient had neither prior cancer history nor
 family history of colonic malignancy. Physical examination was
nremarkable. Digital rectal examination revealed a mass about
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8 cm from the anal verge on the right lateral wall of the middle
rectum. Colonoscopy showed an ulcerated, polypoid tumour of
middle rectum (Fig. 1). Biopsies of this mass taken at the time
of the colonoscopy revealed poorly differentiated SCC of rectum:
atypical SCC (Fig. 2). An abdominal CT scan showed a polypoid
tumour (50 mm × 40 mm)  with multiple lymph nodes in the pelvis.
A CT scan of the chest, abdomen and pelvis was negative for distal
metastases. The stage of the tumour was found to be T3N+M0.
The endoscopic ultrasound and MRI  of the rectum conﬁrmed the
results of colonoscopy and showed multiple lymph nodes in the
pelvis. A positron emission tomography (PET) scan suggested the
rectal tumour to be primary and was negative for distal metastases
(Fig. 3).
The  case was  discussed by the multidisciplinary oncologi-
cal team who decided that chemoradiation followed by surgical
excision should be performed. The patient received a combined
treatment with cisplatin and ﬂuorouracil (5FU) along with external
beam radiation therapy. She then underwent laparoscopic anterior
resection. The standard technique of mesorectal excision and the
concept of sphincter-preserving surgery were respected (anasto-
mosis of the descending colon with the anus). The postoperative
ense.histopathological ﬁndings were in accordance with the diagnosis
of atypical SCC of rectum that was classiﬁed as ypT3NOMO (Fig. 4).
Tumor regression classiﬁcation Dworak was estimated grade 3
(presence of rare tumor cells in ﬁbrous remodeling). The margins of
s Ltd. Open access under CC BY-NC-SA license.
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cFig. 1. Colonoscopy view showing the tumour of middle rectum.
he excised tissue were cancer-free. The lymph nodes were cancer-
ree. The postoperative period was uncomplicated.
. Discussion
Malignant lesions of the rectum include secondary malignant
umours, intraepithelial neoplasm, adenocarcinoma, mucinous
denocarcinoma, adeno-squamous cell carcinoma, carcinoma in
denoma, neuroendocrine neoplasms, signet ring cell carci-
oma, mixed carcinoid-adenocarcinoma, small cell carcinoma,
edullary carcinoma, undifferentiated carcinoma, leiomyosar-
oma, Kaposi’s sarcoma, angiosarcoma, gastrointestinal stromal
umour (GIST), squamous cell carcinoma, malignant lymphomas,
alignant melanoma.
The  incidence of SCC ranges from 0.1 to 0.25 per 1000 colorectal
eoplasms.1 Schmidtmann reported the ﬁrst case of pure SCC of
he colon in a 65-year-old man  in 1919.2 Raiford reported the ﬁrst
ase of squamous cell cancer SCC of the rectum in 1933.3 The SCC
f the rectum is more frequent than SCC of the right colon.4 SCC of
he rectum appears affect individuals with a mean age of 57 years.
ased on a review of the literature, 66% of cases occurred in women
nd 34% in men. Table 1 summarizes some of the reported cases.
The  aetiopathogenicity of SCC of the rectum are still unclear.
everal hypotheses have been proposed. Some suggest that chronic
rritation (radiation exposure) can cause squamous metaplasia and
ig. 2. Poorly differentiated carcinoma composed of large cells with large nuclei, very
ytoplasm (HES ob. 20×). Tumour proliferation shows a low cytoplasmic and membrane PEN  ACCESS
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subsequent tumour development. Hicks et al. suggest that the
pluripotent stem cells are capable of squamous differentiation.5
Others have described the possibility of squamous differentiation
of adenoma and adenocarcinoma.6 Nahas et al. suggest a common
cellular origin for rectal SCC and rectal adenocarcinoma, which is
different from anal SCC.7 The risk factors of SCC of the rectum are
still elusive. There is no ethnic predilection for this tumour. The
association seen between SCC of the rectum and human papil-
loma virus has not been established. Coexisting infections have
been described including entamoeba histolytica colitis and schis-
tosomiasis. Some case reports have found SCC in association with
prostate cancer, ovarian cancer and endometrial cancer.
The  diagnosis of SCC is often delayed. The symptoms can persist
for several weeks to months.8 The symptoms of the patients with
SCC of the rectum are similar to those with adenocarcinoma: rectal
bleeding, change in bowel habits, abdominal pain and weight loss.9
Before labelling the diagnosis as colorectal SCC, Williams et al. have
proposed reasonable criteria which must be fulﬁlled10: absence
of extension of the tumour from the anal squamous epithelium;
absence of evidence of squamous cell carcinoma of any other pri-
mary site; absence of squamous-lined ﬁstula tract to the affected
bowel; conﬁrmation of SCC by histological examination (without
glandular differentiation). In our patient, all of these criteria were
fulﬁlled.
MRI  of the rectum and trans-rectal endoscopic ultrasound R-EUS
provide essential information on therapeutic approach. R-EUS pro-
vides better local lymph node evaluation but it has yet to be shown
to be superior to endo-rectal MRI. Immunohistochemistry helps to
differentiate rectal from anal lesions. The most useful cytokeratins
are CAM 5.2, 34B12 and AE1/AE3.11 CAM 5.2 stains rectal SCC and
adenocarcinoma but not anal SCC.7 It was noted that Rasheed et al.
found SCC Ag to be elevated in three out of six patients.12 Dyson
et al. suggest that the squamous cell carcinoma antigen (SCC Ag)
level is not suitable for initial diagnosis of rectal SCC, but might be
helpful to monitor disease response and progression.11
Most authors conclude that the surgery is the gold standard
treatment for colorectal SCC.1 Based on a review of the litera-
ture, the treatment options in function upon tumour location
include: chemotherapy alone, radiation therapy alone, surgical
excision alone, chemoradiation alone, surgical excision followed
by chemoradiation and chemoradiation followed by surgical
 irregular, often hyperchromatic without keratinization phenomenon. Abundant
staining CK20 (ob. 20×). Cytoplasmic immunostaining CK5/6+++ (ob. 40×).
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Table  1
Squamous cell carcinoma of the colon and rectum – reported cases (selected, data available from 1919 to 2007). LAR = low anterior resection; APR = abdominoperineal
resection;  NA = not available; RC = right colectomy; LC = left colectomy; TAE = transanal excision.
Author Age Sex Location Treatment Outcome
Schmidtmann (1919) 65 M NA NA Died after 1 months
Raiford  (1933) 43 F NA NA Died after 7 months
Catell  & Williams (1943) 63 M Rectum LAR Alive at 3.5 years
Hicks  & Cowling (1955) 90 F Ascending colon NA Died at 1 month
Wiener  et al. (1962) 52 F Rectum APR Died at 1 years
Larizadeh  & Powell (1965) 44 F Hepatic ﬂexure RC Alive at 8 months
Wood  (1967) 58 M Caecum RC NA
Cabrera  et al. (1967) 62 F NA APR NA
50  F NA NA
Minkowitz  et al. (1967) 49 F Rectosigmoid Proctocolectomy Died at 5 months
Gaston  et al. (1967) 65 M Caecum RC Alive at 2 years
Pemberton  & Leendrum (1968) 48 F Ascending colon RC Alive at 2 years
Birnbaum  (1970) 82 M Ascending colon RC NA
Corner  (1971) 34 F APR APR Alive at 13 years
Lewis  et al. (1971) 61 M Caecum RC Died at 10 days
Balfour  (1972) 63 M NA NA Died after 18 months
Horne  & McCulloch (1978) 53 M Caecum RC Dead at 10 months
Crissman  (1978) 72 M Transverse colon Transverse colectomy Dead at 3 days
Burgess  et al. (1979) 43 M Hepatic ﬂexure RH Dead at 1 years
Williams  et al. (1979) NA NA Rectum NA NA
NA  NA
Kahn et al. (1979) 64 M Ascending colon NA NA
Lasser  et al. (1980) 65 F NA NA Alive at 3 years
48  F NA NA Alive 8 months
54  M NA NA Alive 17 months
Hickey  & Corson (1981) 48 F Transverse colon Extended RC Alive at 21 months
Petrelli  et al. (1981) 73 M Sigmoid Palliative colostomy Died at 9 days
Pitella  & Torres (1982) 33 M Ascending colon Ileocolic bypass Dead at 10 days
Hey  & Brandt (1982) NA NA NA NA NA
NA  NA NA NA NA
Lyttle  (1983) 65  F Ascending colon RC Alive at 2 months
Vezeridis  et al. (1983) 56 M Rectum APR Died after 10 months
57 M Transverse colon Colectomy Alive at 14 months
44 M Rectum APR Dead at 9 days
61  F Rectum Chemotherapy Dead at 4 months
66  F Rectum 5-FU and radiation Dead at 15 months
62 F Rectum APR Dead at 13 months
Gould  et al. (1983) 61 M Splenic ﬂexure Ileocolic bypass Dead at 3 months
Francioni  et al. (1983) NA NA NA NA NA
Forouhar  et al. (1984) NA NA NA NA NA
Lafreniere  et al. (1985) 60 M NA TAE Alive at 2 years
Balsano  (1985) 65 M Caecum RC NA
58  M Ascending colon RC NA
Weidner  and Zekan,(1986) 73 M NA NA Died after 4 years
Chulia  et al. (1986) NA NA NA NA NA
Piggott  & Williams (1987) NA NA APR NA Alive at 1 years
Woods  et al. (1987) 57 F NA APR Died after 3 months
Shao  et al. (1987) NA NA RC NA
Prener  et al. (1988) 43 F APR Died after 1 years
77 F Polypectomy Died after 3 years
55 F APR Alive at 3 years
55  M APR Died after months
53  M APR Died after 1 years
Lundquest  et al. (1988) NA NA NA NA NA
Wyatt  (1991) 71 M NA NA Alive at 1 years
Betancourt  et al. (1992) NA NA NA NA NA
Vignale  et al. (1993) NA NA NA NA NA
Yoshida  et al. (1994) 51 M Splenic ﬂexure LC Dead after 39 days
Alekseev et al. (1994) NA NA NA NA NA
Petrelli  et al. (1996) 62 M Rectum APR NA
41  F Caecum RC NA
Juturi  et al. (1999) 61 F Hepatic ﬂexure RC Alive at 18 years
67 M Sigmoid colon LC and chemotherapy Dead after 15 months
Gelas et al. (2002) 47 F NA APR + CT Alive at 16 years
63 M NA APR + CT Died after 14 months
70 F NA APR Died after 18 months
93 M NA NA Died after 4 months
45 F NA LAR Alive at 6 months
43  F NA LAR Alive at 2 years
Bhat  et al. (2003) 55 F NA Hemicolectomy NA
Kim,  2005 53 M NA NA NA
Lam  et al. (2006) 44 F NA LAR NA
Pikarsky  et al. (2006) 57 F NA NA Alive at 7 years
Miyamoto  (2007) 89 M NA Colectomy Died after 3 months
Cheng  et al. (2007) 51 F NA Proctocolectomy NA
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Fig. 3. Positron emission tomography scan.
therapy in a ﬁbrous stroma that are CK5/6+++ and CK20+ (ob.10×).
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Table 2
TMN  classiﬁcation for squamous cell rectal cancer.
Stage T N M
0 Tis N0 M0
I T1 (invasion to the mucosa or submucosa) N0 M0
T2  (invasion to the muscularis propria)
A  T3 (transmural invasion through the
muscularis propria into the perirectal fat)
N0  M0
B T4 (invasion of surrounding organs[) N0 M0
IA T1T2 N0 M0Fig. 4. Presence of rare dystrophic cells remaining after chemo
xcision. In selected cases of stage T1, local excision is appropriate.
ur patient received a combined treatment with cisplatin and
uorouracil (5FU) along with external beam radiation therapy. The
hemoradiation (mitomycin-C or cisplatin.) was followed by sur-
ical excision. When radiation therapy was added preoperatively,
ahas showed there was an increase in sphincter preserving
rocedures from 67% to 71%. Two surgical techniques can be
sed depending upon tumour location: low anterior resection or
bdomino-perineal resection. The abdomino-perineal resection
f the rectum is accompanied with a vast number of morbidity
nd poor long-term patient satisfaction. In our case, low anterior
esection was performed. In selected cases of stage T1, endoscopic
ucosal resection is acceptable. Local excision involves removal
f lesions via the endoscopic resection of mucosa and submucosa.
ee et al. reported a case of squamous cell metaplasia in the rectum
uccessfully treated with argon plasma coagulation.
Tumour TNM stage is the most important predictor of prognosis
f SCC (Table 2). The prognosis of rectal SCC is worse than that for
CC of the other parts of the colon. Comer et al. have suggested a
oorer prognosis for colorectal SCC than adenocarcinoma.9 Galb-
ach et al. have presented a case of 77 year old women who was
perated due to SCC in caecum (no signs of metastases). The patient
ied ﬁve months after the surgery.13
In conclusion, SCC of the rectum are very rare neoplasms, carry
 poor prognosis and treatment selection is difﬁcult. However,IB T3T4 N1 M0
IC Any T N1 M0
IV Any T Any N M1
chemoradiation followed by surgical excision have a role espe-
cially for node-positive patients. It is important to differentiate
this rare pathological feature of the rectum from other rectum
tumours.
Conﬂict of interests statement
None.Funding
None.
 –  O
9 nal of 
E
t
A
o
A
B
w
A
a
R
1
1
1
O
T
p
cCASE  REPORT
0 R.  Kassir et al. / International Jour
thical approval
Informed consent was obtained from the patient in writing for
he publication of this case report and the accompanying images.
 copy of the written consent is available for review and can be
btained from the Editor-in-Chief of this journal on request.
uthor  contributions
Bouarioua and Carmen Adina has the collected data. Sylviane
accot has conceptualized and designed the paper. Radwan Kassir
rote the paper. Joëlle Dubois, Alexia Boueil, Arnaud Patoir and
ntoine Epin has reviewed the paper. Olivier Tiffet has reviewed
nd revised the paper.
eferences
1. Anagnostopoulos G, Sakorafas GH, Kostopoulos P, Grigoriadis K, Pavlakis G, Mar-
gantinis G, et al. Squamous cell carcinoma of the rectum: a case report and review
of the literature. Eur J Cancer Care (Engl) 2005;14:70–4.
2.  Schmidtmann M.  Zur Kenntnis seltener Krebsformen. Virchows Arch 1919;226:
100–18.
3. Raiford TS. Epitheliomata of the lower rectum and anus. Surg Gynecol Obstet
1933;57:21–35.
1
pen Access
his  article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
Surgery Case Reports 5 (2014) 86– 90
4. Juturi JV, Francis B, Koontz PW,  Wilkes JD. Squamous-cell carcinoma of the colon
responsive to combination chemotherapy: report of two cases and review of the
literature. Dis Colon Rectum 1999;42:102–9.
5.  Ouban A, Nawab RA, Coppola D. Diagnostic and pathogenetic implications of
colorectal carcinomas with multidirectional differentiation: a report of 4 cases.
Clin Colorectal Cancer 2002;1:243–8.
6. Jaworski RC, Biankin SA, Baird PJ. Squamous cell carcinoma in situ arising in
inﬂammatory cloacogenic polyps: report of two cases with PCR analysis for HPV
DNA. Pathology 2001;33:312–4.
7. Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR,  et al. Squamous-
cell  carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum
2007;50(September (9)):1393–400.
8. Fu K, Tsujinaka Y, Hamahata Y, Matsuo K, Tsutsumi O. Squamous metaplasia
of  the rectum associated with ulcerative colitis diagnosed using narrow-band
imaging. Endoscopy 2008;40(Suppl. 2):E45–6.
9.  Dyson T, Draganov PV:. Squamous cell cancer of the rectum. World J Gastroenterol
2009;15:4380–6.
0. Williams GT, Blackshaw AJ, Morson BC. Squamous carcinoma of the colorectum
and  its genesis. J Pathol 1979;129:139–47.
1. Dyson T, Draganov PV. Squamous cell cancer of the rectum. World J Gastroenterol
2009;15(September (35)):4380–6.
2. Rasheed S, Yap T, Zia A, McDonald PJ, Glynne-Jones R. Chemo-radiotherapy: an
alternative to surgery for squamous cell carcinoma of the rectum – report of six
patients and literature review. Colorectal Dis 2009;11:191–7.
3. Galbfach PJ, Sygut AR, Spychalski MI,  Winiarski MJ,  Dziki AJ. Squamous cell
carcinoma of caecum – case report. Pol Merkuriusz Lek 2009;26(June (156)):
640–1.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
